nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—HTR1F—trigeminal nerve—bone cancer	0.0893	0.223	CbGeAlD
Zolmitriptan—HTR1B—dura mater—bone cancer	0.0851	0.212	CbGeAlD
Zolmitriptan—HTR1D—dura mater—bone cancer	0.0824	0.205	CbGeAlD
Zolmitriptan—HTR1B—trigeminal nerve—bone cancer	0.0366	0.0912	CbGeAlD
Zolmitriptan—HTR1D—trigeminal nerve—bone cancer	0.0354	0.0883	CbGeAlD
Zolmitriptan—HTR1B—cranial nerve—bone cancer	0.0261	0.065	CbGeAlD
Zolmitriptan—HTR1D—cranial nerve—bone cancer	0.0252	0.0629	CbGeAlD
Zolmitriptan—HTR1D—connective tissue—bone cancer	0.00521	0.013	CbGeAlD
Zolmitriptan—MAOA—connective tissue—bone cancer	0.00397	0.00989	CbGeAlD
Zolmitriptan—HTR1B—spinal cord—bone cancer	0.00357	0.00889	CbGeAlD
Zolmitriptan—Almotriptan—CYP3A4—bone cancer	0.00299	0.562	CrCbGaD
Zolmitriptan—HTR1A—spinal cord—bone cancer	0.00288	0.00717	CbGeAlD
Zolmitriptan—MAOA—tendon—bone cancer	0.00273	0.0068	CbGeAlD
Zolmitriptan—MAOA—spinal cord—bone cancer	0.00263	0.00655	CbGeAlD
Zolmitriptan—Eletriptan—CYP3A4—bone cancer	0.00233	0.438	CrCbGaD
Zolmitriptan—Gastritis—Doxorubicin—bone cancer	0.00102	0.00173	CcSEcCtD
Zolmitriptan—Pain—Cisplatin—bone cancer	0.00102	0.00173	CcSEcCtD
Zolmitriptan—Muscular weakness—Doxorubicin—bone cancer	0.00102	0.00173	CcSEcCtD
Zolmitriptan—Stomatitis—Methotrexate—bone cancer	0.000999	0.0017	CcSEcCtD
Zolmitriptan—Conjunctivitis—Methotrexate—bone cancer	0.000996	0.0017	CcSEcCtD
Zolmitriptan—Dysphagia—Doxorubicin—bone cancer	0.000995	0.00169	CcSEcCtD
Zolmitriptan—Influenza—Doxorubicin—bone cancer	0.000995	0.00169	CcSEcCtD
Zolmitriptan—Pollakiuria—Epirubicin—bone cancer	0.000994	0.00169	CcSEcCtD
Zolmitriptan—Eosinophilia—Doxorubicin—bone cancer	0.000985	0.00168	CcSEcCtD
Zolmitriptan—Sweating—Methotrexate—bone cancer	0.000982	0.00167	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Epirubicin—bone cancer	0.000982	0.00167	CcSEcCtD
Zolmitriptan—Feeling abnormal—Cisplatin—bone cancer	0.000981	0.00167	CcSEcCtD
Zolmitriptan—Weight increased—Epirubicin—bone cancer	0.000979	0.00167	CcSEcCtD
Zolmitriptan—Haematuria—Methotrexate—bone cancer	0.000977	0.00166	CcSEcCtD
Zolmitriptan—Pancreatitis—Doxorubicin—bone cancer	0.000976	0.00166	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Epirubicin—bone cancer	0.00097	0.00165	CcSEcCtD
Zolmitriptan—Angina pectoris—Doxorubicin—bone cancer	0.000969	0.00165	CcSEcCtD
Zolmitriptan—Epistaxis—Methotrexate—bone cancer	0.000967	0.00165	CcSEcCtD
Zolmitriptan—Pneumonia—Epirubicin—bone cancer	0.000965	0.00164	CcSEcCtD
Zolmitriptan—Bronchitis—Doxorubicin—bone cancer	0.000957	0.00163	CcSEcCtD
Zolmitriptan—Body temperature increased—Cisplatin—bone cancer	0.000941	0.0016	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Epirubicin—bone cancer	0.00094	0.0016	CcSEcCtD
Zolmitriptan—Jaundice—Epirubicin—bone cancer	0.000935	0.00159	CcSEcCtD
Zolmitriptan—Stomatitis—Epirubicin—bone cancer	0.000935	0.00159	CcSEcCtD
Zolmitriptan—Conjunctivitis—Epirubicin—bone cancer	0.000932	0.00159	CcSEcCtD
Zolmitriptan—Urinary tract infection—Epirubicin—bone cancer	0.000932	0.00159	CcSEcCtD
Zolmitriptan—Sweating—Epirubicin—bone cancer	0.000919	0.00157	CcSEcCtD
Zolmitriptan—Pollakiuria—Doxorubicin—bone cancer	0.000919	0.00157	CcSEcCtD
Zolmitriptan—Haematuria—Epirubicin—bone cancer	0.000914	0.00156	CcSEcCtD
Zolmitriptan—Pharyngitis—Methotrexate—bone cancer	0.000913	0.00155	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Methotrexate—bone cancer	0.000908	0.00155	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Doxorubicin—bone cancer	0.000908	0.00155	CcSEcCtD
Zolmitriptan—Weight increased—Doxorubicin—bone cancer	0.000906	0.00154	CcSEcCtD
Zolmitriptan—Epistaxis—Epirubicin—bone cancer	0.000904	0.00154	CcSEcCtD
Zolmitriptan—Urethral disorder—Methotrexate—bone cancer	0.000902	0.00154	CcSEcCtD
Zolmitriptan—Sinusitis—Epirubicin—bone cancer	0.0009	0.00153	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Doxorubicin—bone cancer	0.000898	0.00153	CcSEcCtD
Zolmitriptan—Pneumonia—Doxorubicin—bone cancer	0.000892	0.00152	CcSEcCtD
Zolmitriptan—Hypersensitivity—Cisplatin—bone cancer	0.000877	0.00149	CcSEcCtD
Zolmitriptan—Bradycardia—Epirubicin—bone cancer	0.000876	0.00149	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Doxorubicin—bone cancer	0.00087	0.00148	CcSEcCtD
Zolmitriptan—Stomatitis—Doxorubicin—bone cancer	0.000865	0.00147	CcSEcCtD
Zolmitriptan—Jaundice—Doxorubicin—bone cancer	0.000865	0.00147	CcSEcCtD
Zolmitriptan—Rhinitis—Epirubicin—bone cancer	0.000863	0.00147	CcSEcCtD
Zolmitriptan—Urinary tract infection—Doxorubicin—bone cancer	0.000862	0.00147	CcSEcCtD
Zolmitriptan—Conjunctivitis—Doxorubicin—bone cancer	0.000862	0.00147	CcSEcCtD
Zolmitriptan—Tinnitus—Methotrexate—bone cancer	0.000858	0.00146	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Epirubicin—bone cancer	0.000857	0.00146	CcSEcCtD
Zolmitriptan—Asthenia—Cisplatin—bone cancer	0.000854	0.00145	CcSEcCtD
Zolmitriptan—Pharyngitis—Epirubicin—bone cancer	0.000854	0.00145	CcSEcCtD
Zolmitriptan—Cardiac disorder—Methotrexate—bone cancer	0.000854	0.00145	CcSEcCtD
Zolmitriptan—Sweating—Doxorubicin—bone cancer	0.000851	0.00145	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Epirubicin—bone cancer	0.00085	0.00145	CcSEcCtD
Zolmitriptan—Oedema peripheral—Epirubicin—bone cancer	0.000848	0.00144	CcSEcCtD
Zolmitriptan—Haematuria—Doxorubicin—bone cancer	0.000846	0.00144	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Epirubicin—bone cancer	0.000846	0.00144	CcSEcCtD
Zolmitriptan—Urethral disorder—Epirubicin—bone cancer	0.000844	0.00144	CcSEcCtD
Zolmitriptan—Epistaxis—Doxorubicin—bone cancer	0.000837	0.00142	CcSEcCtD
Zolmitriptan—Angiopathy—Methotrexate—bone cancer	0.000835	0.00142	CcSEcCtD
Zolmitriptan—Sinusitis—Doxorubicin—bone cancer	0.000832	0.00142	CcSEcCtD
Zolmitriptan—Immune system disorder—Methotrexate—bone cancer	0.000831	0.00141	CcSEcCtD
Zolmitriptan—Chills—Methotrexate—bone cancer	0.000825	0.00141	CcSEcCtD
Zolmitriptan—Diarrhoea—Cisplatin—bone cancer	0.000815	0.00139	CcSEcCtD
Zolmitriptan—Bradycardia—Doxorubicin—bone cancer	0.000811	0.00138	CcSEcCtD
Zolmitriptan—Tinnitus—Epirubicin—bone cancer	0.000803	0.00137	CcSEcCtD
Zolmitriptan—Erythema—Methotrexate—bone cancer	0.000801	0.00136	CcSEcCtD
Zolmitriptan—Cardiac disorder—Epirubicin—bone cancer	0.000799	0.00136	CcSEcCtD
Zolmitriptan—Rhinitis—Doxorubicin—bone cancer	0.000799	0.00136	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Doxorubicin—bone cancer	0.000793	0.00135	CcSEcCtD
Zolmitriptan—Pharyngitis—Doxorubicin—bone cancer	0.000791	0.00135	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Doxorubicin—bone cancer	0.000787	0.00134	CcSEcCtD
Zolmitriptan—Oedema peripheral—Doxorubicin—bone cancer	0.000785	0.00134	CcSEcCtD
Zolmitriptan—Dysgeusia—Methotrexate—bone cancer	0.000784	0.00134	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Doxorubicin—bone cancer	0.000783	0.00133	CcSEcCtD
Zolmitriptan—Angiopathy—Epirubicin—bone cancer	0.000781	0.00133	CcSEcCtD
Zolmitriptan—Urethral disorder—Doxorubicin—bone cancer	0.000781	0.00133	CcSEcCtD
Zolmitriptan—Immune system disorder—Epirubicin—bone cancer	0.000778	0.00132	CcSEcCtD
Zolmitriptan—Back pain—Methotrexate—bone cancer	0.000775	0.00132	CcSEcCtD
Zolmitriptan—Chills—Epirubicin—bone cancer	0.000772	0.00132	CcSEcCtD
Zolmitriptan—Arrhythmia—Epirubicin—bone cancer	0.000769	0.00131	CcSEcCtD
Zolmitriptan—Vomiting—Cisplatin—bone cancer	0.000757	0.00129	CcSEcCtD
Zolmitriptan—Rash—Cisplatin—bone cancer	0.000751	0.00128	CcSEcCtD
Zolmitriptan—Dermatitis—Cisplatin—bone cancer	0.00075	0.00128	CcSEcCtD
Zolmitriptan—Erythema—Epirubicin—bone cancer	0.000749	0.00128	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Methotrexate—bone cancer	0.000743	0.00127	CcSEcCtD
Zolmitriptan—Tinnitus—Doxorubicin—bone cancer	0.000743	0.00126	CcSEcCtD
Zolmitriptan—Cardiac disorder—Doxorubicin—bone cancer	0.000739	0.00126	CcSEcCtD
Zolmitriptan—Tension—Epirubicin—bone cancer	0.000735	0.00125	CcSEcCtD
Zolmitriptan—Dysgeusia—Epirubicin—bone cancer	0.000734	0.00125	CcSEcCtD
Zolmitriptan—Nervousness—Epirubicin—bone cancer	0.000728	0.00124	CcSEcCtD
Zolmitriptan—Back pain—Epirubicin—bone cancer	0.000725	0.00123	CcSEcCtD
Zolmitriptan—Angiopathy—Doxorubicin—bone cancer	0.000723	0.00123	CcSEcCtD
Zolmitriptan—Malaise—Methotrexate—bone cancer	0.000722	0.00123	CcSEcCtD
Zolmitriptan—Muscle spasms—Epirubicin—bone cancer	0.00072	0.00123	CcSEcCtD
Zolmitriptan—Immune system disorder—Doxorubicin—bone cancer	0.000719	0.00122	CcSEcCtD
Zolmitriptan—Vertigo—Methotrexate—bone cancer	0.000719	0.00122	CcSEcCtD
Zolmitriptan—Leukopenia—Methotrexate—bone cancer	0.000717	0.00122	CcSEcCtD
Zolmitriptan—Chills—Doxorubicin—bone cancer	0.000715	0.00122	CcSEcCtD
Zolmitriptan—Arrhythmia—Doxorubicin—bone cancer	0.000712	0.00121	CcSEcCtD
Zolmitriptan—Nausea—Cisplatin—bone cancer	0.000707	0.0012	CcSEcCtD
Zolmitriptan—Cough—Methotrexate—bone cancer	0.000699	0.00119	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Epirubicin—bone cancer	0.000695	0.00118	CcSEcCtD
Zolmitriptan—Convulsion—Methotrexate—bone cancer	0.000694	0.00118	CcSEcCtD
Zolmitriptan—Erythema—Doxorubicin—bone cancer	0.000693	0.00118	CcSEcCtD
Zolmitriptan—Agitation—Epirubicin—bone cancer	0.000689	0.00117	CcSEcCtD
Zolmitriptan—Arthralgia—Methotrexate—bone cancer	0.000682	0.00116	CcSEcCtD
Zolmitriptan—Myalgia—Methotrexate—bone cancer	0.000682	0.00116	CcSEcCtD
Zolmitriptan—Chest pain—Methotrexate—bone cancer	0.000682	0.00116	CcSEcCtD
Zolmitriptan—Tension—Doxorubicin—bone cancer	0.00068	0.00116	CcSEcCtD
Zolmitriptan—Dysgeusia—Doxorubicin—bone cancer	0.000679	0.00116	CcSEcCtD
Zolmitriptan—Malaise—Epirubicin—bone cancer	0.000676	0.00115	CcSEcCtD
Zolmitriptan—Discomfort—Methotrexate—bone cancer	0.000674	0.00115	CcSEcCtD
Zolmitriptan—Nervousness—Doxorubicin—bone cancer	0.000673	0.00115	CcSEcCtD
Zolmitriptan—Vertigo—Epirubicin—bone cancer	0.000673	0.00115	CcSEcCtD
Zolmitriptan—Syncope—Epirubicin—bone cancer	0.000672	0.00114	CcSEcCtD
Zolmitriptan—Leukopenia—Epirubicin—bone cancer	0.000671	0.00114	CcSEcCtD
Zolmitriptan—Back pain—Doxorubicin—bone cancer	0.000671	0.00114	CcSEcCtD
Zolmitriptan—Muscle spasms—Doxorubicin—bone cancer	0.000667	0.00114	CcSEcCtD
Zolmitriptan—Palpitations—Epirubicin—bone cancer	0.000662	0.00113	CcSEcCtD
Zolmitriptan—Confusional state—Methotrexate—bone cancer	0.000659	0.00112	CcSEcCtD
Zolmitriptan—Loss of consciousness—Epirubicin—bone cancer	0.000659	0.00112	CcSEcCtD
Zolmitriptan—Cough—Epirubicin—bone cancer	0.000654	0.00111	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Methotrexate—bone cancer	0.000654	0.00111	CcSEcCtD
Zolmitriptan—Convulsion—Epirubicin—bone cancer	0.000649	0.00111	CcSEcCtD
Zolmitriptan—Infection—Methotrexate—bone cancer	0.000649	0.00111	CcSEcCtD
Zolmitriptan—Hypertension—Epirubicin—bone cancer	0.000647	0.0011	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Doxorubicin—bone cancer	0.000643	0.0011	CcSEcCtD
Zolmitriptan—Nervous system disorder—Methotrexate—bone cancer	0.000641	0.00109	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Methotrexate—bone cancer	0.00064	0.00109	CcSEcCtD
Zolmitriptan—Arthralgia—Epirubicin—bone cancer	0.000638	0.00109	CcSEcCtD
Zolmitriptan—Chest pain—Epirubicin—bone cancer	0.000638	0.00109	CcSEcCtD
Zolmitriptan—Myalgia—Epirubicin—bone cancer	0.000638	0.00109	CcSEcCtD
Zolmitriptan—Agitation—Doxorubicin—bone cancer	0.000637	0.00108	CcSEcCtD
Zolmitriptan—Anxiety—Epirubicin—bone cancer	0.000636	0.00108	CcSEcCtD
Zolmitriptan—Skin disorder—Methotrexate—bone cancer	0.000635	0.00108	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Methotrexate—bone cancer	0.000632	0.00108	CcSEcCtD
Zolmitriptan—Discomfort—Epirubicin—bone cancer	0.00063	0.00107	CcSEcCtD
Zolmitriptan—Malaise—Doxorubicin—bone cancer	0.000625	0.00106	CcSEcCtD
Zolmitriptan—Dry mouth—Epirubicin—bone cancer	0.000624	0.00106	CcSEcCtD
Zolmitriptan—Vertigo—Doxorubicin—bone cancer	0.000623	0.00106	CcSEcCtD
Zolmitriptan—Anorexia—Methotrexate—bone cancer	0.000623	0.00106	CcSEcCtD
Zolmitriptan—Syncope—Doxorubicin—bone cancer	0.000622	0.00106	CcSEcCtD
Zolmitriptan—Leukopenia—Doxorubicin—bone cancer	0.000621	0.00106	CcSEcCtD
Zolmitriptan—Confusional state—Epirubicin—bone cancer	0.000617	0.00105	CcSEcCtD
Zolmitriptan—Palpitations—Doxorubicin—bone cancer	0.000613	0.00104	CcSEcCtD
Zolmitriptan—Oedema—Epirubicin—bone cancer	0.000612	0.00104	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Epirubicin—bone cancer	0.000612	0.00104	CcSEcCtD
Zolmitriptan—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.000611	0.0975	CbGpPWpGaD
Zolmitriptan—Loss of consciousness—Doxorubicin—bone cancer	0.000609	0.00104	CcSEcCtD
Zolmitriptan—Infection—Epirubicin—bone cancer	0.000608	0.00103	CcSEcCtD
Zolmitriptan—Cough—Doxorubicin—bone cancer	0.000605	0.00103	CcSEcCtD
Zolmitriptan—Shock—Epirubicin—bone cancer	0.000602	0.00102	CcSEcCtD
Zolmitriptan—Convulsion—Doxorubicin—bone cancer	0.000601	0.00102	CcSEcCtD
Zolmitriptan—Nervous system disorder—Epirubicin—bone cancer	0.0006	0.00102	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Epirubicin—bone cancer	0.000599	0.00102	CcSEcCtD
Zolmitriptan—Hypertension—Doxorubicin—bone cancer	0.000599	0.00102	CcSEcCtD
Zolmitriptan—Tachycardia—Epirubicin—bone cancer	0.000597	0.00102	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000595	0.00101	CcSEcCtD
Zolmitriptan—Skin disorder—Epirubicin—bone cancer	0.000594	0.00101	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Epirubicin—bone cancer	0.000591	0.00101	CcSEcCtD
Zolmitriptan—Insomnia—Methotrexate—bone cancer	0.000591	0.00101	CcSEcCtD
Zolmitriptan—Chest pain—Doxorubicin—bone cancer	0.00059	0.00101	CcSEcCtD
Zolmitriptan—Arthralgia—Doxorubicin—bone cancer	0.00059	0.00101	CcSEcCtD
Zolmitriptan—Myalgia—Doxorubicin—bone cancer	0.00059	0.00101	CcSEcCtD
Zolmitriptan—Anxiety—Doxorubicin—bone cancer	0.000588	0.001	CcSEcCtD
Zolmitriptan—Paraesthesia—Methotrexate—bone cancer	0.000587	0.000999	CcSEcCtD
Zolmitriptan—Discomfort—Doxorubicin—bone cancer	0.000583	0.000993	CcSEcCtD
Zolmitriptan—Anorexia—Epirubicin—bone cancer	0.000583	0.000993	CcSEcCtD
Zolmitriptan—Dyspnoea—Methotrexate—bone cancer	0.000583	0.000992	CcSEcCtD
Zolmitriptan—Somnolence—Methotrexate—bone cancer	0.000581	0.000989	CcSEcCtD
Zolmitriptan—Dry mouth—Doxorubicin—bone cancer	0.000577	0.000983	CcSEcCtD
Zolmitriptan—Dyspepsia—Methotrexate—bone cancer	0.000575	0.000979	CcSEcCtD
Zolmitriptan—Confusional state—Doxorubicin—bone cancer	0.000571	0.000972	CcSEcCtD
Zolmitriptan—Decreased appetite—Methotrexate—bone cancer	0.000568	0.000967	CcSEcCtD
Zolmitriptan—Oedema—Doxorubicin—bone cancer	0.000566	0.000963	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Doxorubicin—bone cancer	0.000566	0.000963	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Methotrexate—bone cancer	0.000564	0.000961	CcSEcCtD
Zolmitriptan—Infection—Doxorubicin—bone cancer	0.000562	0.000957	CcSEcCtD
Zolmitriptan—Pain—Methotrexate—bone cancer	0.000559	0.000952	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000557	0.000949	CcSEcCtD
Zolmitriptan—Shock—Doxorubicin—bone cancer	0.000557	0.000948	CcSEcCtD
Zolmitriptan—Nervous system disorder—Doxorubicin—bone cancer	0.000555	0.000945	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Doxorubicin—bone cancer	0.000554	0.000943	CcSEcCtD
Zolmitriptan—Insomnia—Epirubicin—bone cancer	0.000553	0.000942	CcSEcCtD
Zolmitriptan—Tachycardia—Doxorubicin—bone cancer	0.000552	0.00094	CcSEcCtD
Zolmitriptan—Skin disorder—Doxorubicin—bone cancer	0.00055	0.000936	CcSEcCtD
Zolmitriptan—Paraesthesia—Epirubicin—bone cancer	0.000549	0.000935	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Doxorubicin—bone cancer	0.000547	0.000931	CcSEcCtD
Zolmitriptan—Dyspnoea—Epirubicin—bone cancer	0.000545	0.000928	CcSEcCtD
Zolmitriptan—Somnolence—Epirubicin—bone cancer	0.000544	0.000926	CcSEcCtD
Zolmitriptan—Anorexia—Doxorubicin—bone cancer	0.000539	0.000918	CcSEcCtD
Zolmitriptan—Feeling abnormal—Methotrexate—bone cancer	0.000539	0.000917	CcSEcCtD
Zolmitriptan—Dyspepsia—Epirubicin—bone cancer	0.000538	0.000917	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Methotrexate—bone cancer	0.000534	0.00091	CcSEcCtD
Zolmitriptan—Decreased appetite—Epirubicin—bone cancer	0.000532	0.000905	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Epirubicin—bone cancer	0.000528	0.000899	CcSEcCtD
Zolmitriptan—Pain—Epirubicin—bone cancer	0.000523	0.00089	CcSEcCtD
Zolmitriptan—Constipation—Epirubicin—bone cancer	0.000523	0.00089	CcSEcCtD
Zolmitriptan—Urticaria—Methotrexate—bone cancer	0.000519	0.000884	CcSEcCtD
Zolmitriptan—Abdominal pain—Methotrexate—bone cancer	0.000517	0.00088	CcSEcCtD
Zolmitriptan—Body temperature increased—Methotrexate—bone cancer	0.000517	0.00088	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000516	0.000878	CcSEcCtD
Zolmitriptan—Insomnia—Doxorubicin—bone cancer	0.000512	0.000871	CcSEcCtD
Zolmitriptan—Paraesthesia—Doxorubicin—bone cancer	0.000508	0.000865	CcSEcCtD
Zolmitriptan—Dyspnoea—Doxorubicin—bone cancer	0.000505	0.000859	CcSEcCtD
Zolmitriptan—Feeling abnormal—Epirubicin—bone cancer	0.000504	0.000858	CcSEcCtD
Zolmitriptan—Somnolence—Doxorubicin—bone cancer	0.000503	0.000857	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Epirubicin—bone cancer	0.0005	0.000852	CcSEcCtD
Zolmitriptan—Dyspepsia—Doxorubicin—bone cancer	0.000498	0.000848	CcSEcCtD
Zolmitriptan—Decreased appetite—Doxorubicin—bone cancer	0.000492	0.000838	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000489	0.000832	CcSEcCtD
Zolmitriptan—Urticaria—Epirubicin—bone cancer	0.000486	0.000827	CcSEcCtD
Zolmitriptan—Constipation—Doxorubicin—bone cancer	0.000484	0.000824	CcSEcCtD
Zolmitriptan—Pain—Doxorubicin—bone cancer	0.000484	0.000824	CcSEcCtD
Zolmitriptan—Body temperature increased—Epirubicin—bone cancer	0.000483	0.000823	CcSEcCtD
Zolmitriptan—Abdominal pain—Epirubicin—bone cancer	0.000483	0.000823	CcSEcCtD
Zolmitriptan—Hypersensitivity—Methotrexate—bone cancer	0.000482	0.00082	CcSEcCtD
Zolmitriptan—Asthenia—Methotrexate—bone cancer	0.000469	0.000798	CcSEcCtD
Zolmitriptan—Feeling abnormal—Doxorubicin—bone cancer	0.000466	0.000794	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Doxorubicin—bone cancer	0.000463	0.000788	CcSEcCtD
Zolmitriptan—Pruritus—Methotrexate—bone cancer	0.000462	0.000787	CcSEcCtD
Zolmitriptan—Hypersensitivity—Epirubicin—bone cancer	0.000451	0.000767	CcSEcCtD
Zolmitriptan—Urticaria—Doxorubicin—bone cancer	0.00045	0.000765	CcSEcCtD
Zolmitriptan—Body temperature increased—Doxorubicin—bone cancer	0.000447	0.000762	CcSEcCtD
Zolmitriptan—Abdominal pain—Doxorubicin—bone cancer	0.000447	0.000762	CcSEcCtD
Zolmitriptan—Diarrhoea—Methotrexate—bone cancer	0.000447	0.000761	CcSEcCtD
Zolmitriptan—Asthenia—Epirubicin—bone cancer	0.000439	0.000747	CcSEcCtD
Zolmitriptan—Pruritus—Epirubicin—bone cancer	0.000433	0.000737	CcSEcCtD
Zolmitriptan—Dizziness—Methotrexate—bone cancer	0.000432	0.000736	CcSEcCtD
Zolmitriptan—Diarrhoea—Epirubicin—bone cancer	0.000418	0.000712	CcSEcCtD
Zolmitriptan—Hypersensitivity—Doxorubicin—bone cancer	0.000417	0.00071	CcSEcCtD
Zolmitriptan—Vomiting—Methotrexate—bone cancer	0.000416	0.000707	CcSEcCtD
Zolmitriptan—Rash—Methotrexate—bone cancer	0.000412	0.000702	CcSEcCtD
Zolmitriptan—Dermatitis—Methotrexate—bone cancer	0.000412	0.000701	CcSEcCtD
Zolmitriptan—Headache—Methotrexate—bone cancer	0.000409	0.000697	CcSEcCtD
Zolmitriptan—Asthenia—Doxorubicin—bone cancer	0.000406	0.000691	CcSEcCtD
Zolmitriptan—Dizziness—Epirubicin—bone cancer	0.000404	0.000689	CcSEcCtD
Zolmitriptan—Pruritus—Doxorubicin—bone cancer	0.0004	0.000682	CcSEcCtD
Zolmitriptan—Vomiting—Epirubicin—bone cancer	0.000389	0.000662	CcSEcCtD
Zolmitriptan—Nausea—Methotrexate—bone cancer	0.000388	0.000661	CcSEcCtD
Zolmitriptan—Diarrhoea—Doxorubicin—bone cancer	0.000387	0.000659	CcSEcCtD
Zolmitriptan—Rash—Epirubicin—bone cancer	0.000386	0.000657	CcSEcCtD
Zolmitriptan—Dermatitis—Epirubicin—bone cancer	0.000385	0.000656	CcSEcCtD
Zolmitriptan—Headache—Epirubicin—bone cancer	0.000383	0.000652	CcSEcCtD
Zolmitriptan—Dizziness—Doxorubicin—bone cancer	0.000374	0.000637	CcSEcCtD
Zolmitriptan—Nausea—Epirubicin—bone cancer	0.000363	0.000619	CcSEcCtD
Zolmitriptan—Vomiting—Doxorubicin—bone cancer	0.00036	0.000613	CcSEcCtD
Zolmitriptan—Rash—Doxorubicin—bone cancer	0.000357	0.000608	CcSEcCtD
Zolmitriptan—Dermatitis—Doxorubicin—bone cancer	0.000356	0.000607	CcSEcCtD
Zolmitriptan—Headache—Doxorubicin—bone cancer	0.000355	0.000604	CcSEcCtD
Zolmitriptan—Nausea—Doxorubicin—bone cancer	0.000336	0.000572	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—FEV—bone cancer	0.000257	0.041	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCRs, Other—GRM1—bone cancer	0.000238	0.038	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000224	0.0358	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—FEV—bone cancer	0.000218	0.0348	CbGpPWpGaD
Zolmitriptan—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000201	0.032	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCRs, Other—SMO—bone cancer	0.000168	0.0268	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—RGS1—bone cancer	0.000129	0.0205	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—GRM4—bone cancer	0.000129	0.0205	CbGpPWpGaD
Zolmitriptan—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000116	0.0185	CbGpPWpGaD
Zolmitriptan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000108	0.0173	CbGpPWpGaD
Zolmitriptan—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000105	0.0168	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000101	0.0161	CbGpPWpGaD
Zolmitriptan—CYP1A2—Xenobiotics—CYP3A4—bone cancer	9.69e-05	0.0155	CbGpPWpGaD
Zolmitriptan—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	9.32e-05	0.0149	CbGpPWpGaD
Zolmitriptan—MAOA—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	8.84e-05	0.0141	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	8.64e-05	0.0138	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—RGS1—bone cancer	8.23e-05	0.0131	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—GRM4—bone cancer	8.23e-05	0.0131	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—RGS1—bone cancer	8.06e-05	0.0129	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—GRM4—bone cancer	8.06e-05	0.0129	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—GRM4—bone cancer	7.8e-05	0.0124	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—GRM1—bone cancer	6.76e-05	0.0108	CbGpPWpGaD
Zolmitriptan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	6.34e-05	0.0101	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—RGS1—bone cancer	6.14e-05	0.00979	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—GRM4—bone cancer	6.14e-05	0.00979	CbGpPWpGaD
Zolmitriptan—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	5.46e-05	0.00871	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—GRM4—bone cancer	4.99e-05	0.00795	CbGpPWpGaD
Zolmitriptan—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	4.98e-05	0.00794	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—GRM4—bone cancer	4.88e-05	0.00778	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—SMO—bone cancer	4.76e-05	0.00759	CbGpPWpGaD
Zolmitriptan—MAOA—Biological oxidations—CYP3A4—bone cancer	4.7e-05	0.00749	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—GRM4—bone cancer	4.41e-05	0.00703	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—RGS1—bone cancer	4.41e-05	0.00703	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—GRM1—bone cancer	4.32e-05	0.00689	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—GRM1—bone cancer	4.23e-05	0.00675	CbGpPWpGaD
Zolmitriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	4.02e-05	0.00642	CbGpPWpGaD
Zolmitriptan—MAOA—Biological oxidations—GSTP1—bone cancer	4.02e-05	0.00641	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—RGS1—bone cancer	4e-05	0.00638	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—GRM4—bone cancer	4e-05	0.00638	CbGpPWpGaD
Zolmitriptan—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	3.97e-05	0.00633	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—GRM1—bone cancer	3.82e-05	0.00609	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—GRM4—bone cancer	3.72e-05	0.00593	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—GRM1—bone cancer	3.47e-05	0.00553	CbGpPWpGaD
Zolmitriptan—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	3.26e-05	0.0052	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—GRM1—bone cancer	3.22e-05	0.00514	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—SMO—bone cancer	3.05e-05	0.00486	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—SMO—bone cancer	2.98e-05	0.00476	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—GRM4—bone cancer	2.82e-05	0.00449	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—RGS1—bone cancer	2.82e-05	0.00449	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NDUFA12—bone cancer	2.82e-05	0.00449	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—RGS1—bone cancer	2.76e-05	0.0044	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—GRM4—bone cancer	2.76e-05	0.0044	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	2.68e-05	0.00428	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—GRM4—bone cancer	2.56e-05	0.00408	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—RGS1—bone cancer	2.56e-05	0.00408	CbGpPWpGaD
Zolmitriptan—CYP1A2—Phase II conjugation—GSTP1—bone cancer	2.53e-05	0.00404	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—GRM4—bone cancer	2.51e-05	0.00399	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—RGS1—bone cancer	2.51e-05	0.00399	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—GNA11—bone cancer	2.46e-05	0.00393	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—SMO—bone cancer	2.44e-05	0.0039	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—GRM1—bone cancer	2.44e-05	0.0039	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—GRM1—bone cancer	2.39e-05	0.00381	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RGS1—bone cancer	2.36e-05	0.00377	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—GRM4—bone cancer	2.36e-05	0.00377	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NT5C3A—bone cancer	2.33e-05	0.00372	CbGpPWpGaD
Zolmitriptan—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	2.29e-05	0.00365	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—BRAF—bone cancer	2.28e-05	0.00364	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—SMO—bone cancer	2.27e-05	0.00362	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—GNA11—bone cancer	2.24e-05	0.00356	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—IL3—bone cancer	2.23e-05	0.00356	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—GRM1—bone cancer	2.22e-05	0.00354	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	2.21e-05	0.00352	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—GRM1—bone cancer	2.17e-05	0.00346	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—RGS1—bone cancer	2.1e-05	0.00335	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—GRM4—bone cancer	2.1e-05	0.00335	CbGpPWpGaD
Zolmitriptan—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	2.06e-05	0.00329	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—GRM1—bone cancer	2.05e-05	0.00327	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—JUN—bone cancer	2.03e-05	0.00324	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL3—bone cancer	2.03e-05	0.00323	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	1.99e-05	0.00317	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—MDM2—bone cancer	1.91e-05	0.00305	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—RGS1—bone cancer	1.91e-05	0.00304	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—GRM4—bone cancer	1.91e-05	0.00304	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—GRM1—bone cancer	1.82e-05	0.00291	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—BRAF—bone cancer	1.75e-05	0.00279	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—CYP3A4—bone cancer	1.73e-05	0.00276	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—JUN—bone cancer	1.72e-05	0.00275	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	1.71e-05	0.00272	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—GRM1—bone cancer	1.65e-05	0.00264	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—GNA11—bone cancer	1.57e-05	0.00251	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	1.56e-05	0.00249	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	1.56e-05	0.00249	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—SMO—bone cancer	1.56e-05	0.00249	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—GNA11—bone cancer	1.54e-05	0.00246	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—SMO—bone cancer	1.53e-05	0.00244	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GRM4—bone cancer	1.51e-05	0.00241	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RGS1—bone cancer	1.51e-05	0.00241	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—GSTP1—bone cancer	1.48e-05	0.00236	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GRM4—bone cancer	1.48e-05	0.00236	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RGS1—bone cancer	1.48e-05	0.00236	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—MDM2—bone cancer	1.47e-05	0.00234	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	1.46e-05	0.00233	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SMO—bone cancer	1.44e-05	0.0023	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—GNA11—bone cancer	1.43e-05	0.00228	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—IL3—bone cancer	1.43e-05	0.00228	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—GNA11—bone cancer	1.4e-05	0.00223	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—IL3—bone cancer	1.4e-05	0.00223	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—GNA11—bone cancer	1.32e-05	0.00211	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GRM1—bone cancer	1.31e-05	0.00209	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL3—bone cancer	1.3e-05	0.00207	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GRM1—bone cancer	1.28e-05	0.00205	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL3—bone cancer	1.27e-05	0.00202	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ATF1—bone cancer	1.23e-05	0.00196	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL3—bone cancer	1.2e-05	0.00191	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—GNA11—bone cancer	1.17e-05	0.00187	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—SMO—bone cancer	1.17e-05	0.00186	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GRM4—bone cancer	1.13e-05	0.0018	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RGS1—bone cancer	1.13e-05	0.0018	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—GNA11—bone cancer	1.07e-05	0.0017	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—IL3—bone cancer	1.06e-05	0.0017	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NDUFA12—bone cancer	1.04e-05	0.00166	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TGFBR2—bone cancer	1.02e-05	0.00163	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ENO2—bone cancer	1.02e-05	0.00163	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GRM1—bone cancer	9.77e-06	0.00156	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL3—bone cancer	9.67e-06	0.00154	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IGF1R—bone cancer	9.63e-06	0.00154	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—DHFR—bone cancer	9.48e-06	0.00151	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SMO—bone cancer	9.23e-06	0.00147	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SMO—bone cancer	9.04e-06	0.00144	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GNA11—bone cancer	8.86e-06	0.00141	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NT5C3A—bone cancer	8.61e-06	0.00137	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GNA11—bone cancer	8.44e-06	0.00135	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GNA11—bone cancer	8.27e-06	0.00132	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP3A4—bone cancer	8.03e-06	0.00128	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ATF1—bone cancer	7.85e-06	0.00125	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ATF1—bone cancer	7.69e-06	0.00123	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL3—bone cancer	7.66e-06	0.00122	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL3—bone cancer	7.5e-06	0.0012	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KIT—bone cancer	6.99e-06	0.00111	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SMO—bone cancer	6.89e-06	0.0011	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTP1—bone cancer	6.87e-06	0.0011	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—BRAF—bone cancer	6.57e-06	0.00105	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TGFBR2—bone cancer	6.55e-06	0.00104	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TGFBR2—bone cancer	6.41e-06	0.00102	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—EGFR—bone cancer	6.37e-06	0.00101	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GNA11—bone cancer	6.3e-06	0.001	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF1R—bone cancer	6.16e-06	0.000982	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF1R—bone cancer	6.03e-06	0.000962	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ATF1—bone cancer	5.86e-06	0.000934	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL3—bone cancer	5.71e-06	0.000911	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MDM2—bone cancer	5.5e-06	0.000877	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TGFBR2—bone cancer	4.88e-06	0.000779	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—JUN—bone cancer	4.78e-06	0.000763	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MMP9—bone cancer	4.65e-06	0.000742	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF1R—bone cancer	4.6e-06	0.000733	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KIT—bone cancer	4.47e-06	0.000712	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KIT—bone cancer	4.37e-06	0.000698	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BRAF—bone cancer	4.2e-06	0.00067	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BRAF—bone cancer	4.11e-06	0.000656	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—EGFR—bone cancer	4.07e-06	0.000649	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—EGFR—bone cancer	3.99e-06	0.000636	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ENO2—bone cancer	3.77e-06	0.000601	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EGFR—bone cancer	3.76e-06	0.0006	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—bone cancer	3.56e-06	0.000568	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MDM2—bone cancer	3.52e-06	0.000561	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—DHFR—bone cancer	3.5e-06	0.000558	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MDM2—bone cancer	3.45e-06	0.000549	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KIT—bone cancer	3.33e-06	0.000531	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GNA11—bone cancer	3.27e-06	0.000521	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—bone cancer	3.16e-06	0.000503	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BRAF—bone cancer	3.13e-06	0.000499	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—JUN—bone cancer	3.06e-06	0.000488	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—EGFR—bone cancer	3.04e-06	0.000484	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—JUN—bone cancer	2.99e-06	0.000478	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MMP9—bone cancer	2.98e-06	0.000474	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP3A4—bone cancer	2.96e-06	0.000472	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.95e-06	0.00047	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP9—bone cancer	2.91e-06	0.000465	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MDM2—bone cancer	2.62e-06	0.000419	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTP1—bone cancer	2.53e-06	0.000404	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGFR—bone cancer	2.4e-06	0.000383	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGFR—bone cancer	2.35e-06	0.000375	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JUN—bone cancer	2.28e-06	0.000364	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP9—bone cancer	2.22e-06	0.000354	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—bone cancer	2.02e-06	0.000322	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—bone cancer	1.98e-06	0.000315	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGFR—bone cancer	1.79e-06	0.000286	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—bone cancer	1.51e-06	0.00024	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—bone cancer	1.31e-06	0.000209	CbGpPWpGaD
